Legacy Bridge’s Gilead Sciences GILD Stock Holding History

Legacy Bridge’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-116	Closed	-$14.2K	–	389
2025 Q4	$14.2K	Buy	+116	New	+$14.1K	0.01%	283
2023 Q1	–	Sell	-354	Closed	-$30.4K	–	301
2022 Q4	$30.4K	Buy	+354	New	+$28K	0.02%	211
2022 Q2	–	Sell	-145	Closed	-$9K	–	296
2022 Q1	$9K	Hold	145	–	–	0.01%	266
2021 Q4	$11K	Hold	145	–	–	0.01%	267
2021 Q3	$10K	Sell	145 -235	-62%	-$16.5K	0.01%	260
2021 Q2	$26K	Sell	380 -200	-34%	-$13.4K	0.01%	225
2021 Q1	$37K	Hold	580	–	–	0.02%	206
2020 Q4	$34K	Hold	580	–	–	0.02%	202
2020 Q3	$37K	Hold	580	–	–	0.03%	189
2020 Q2	$45K	Sell	580 -356	-38%	-$27.3K	0.05%	180
2020 Q1	$70K	Hold	936	–	–	0.09%	153
2019 Q4	$61K	Sell	936 -1,669	-64%	-$109K	0.05%	178
2019 Q3	$165K	Sell	2,605 -356	-12%	-$23.3K	0.16%	139
2019 Q2	$200K	Hold	2,961	–	–	0.19%	127
2019 Q1	$192K	Hold	2,961	–	–	0.2%	126
2018 Q4	$185K	Buy	+2,961	New	+$207K	0.23%	121

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Legacy Bridge's GILD Position: Q1 2026 in Review

Legacy Bridge sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 116 shares — an estimated $14.2K sold.

Legacy Bridge first reported a position in GILD in Q4 2018 and held it in 16 quarters. The position peaked at $200K in Q2 2019. 2,327 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Legacy Bridge reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Legacy Bridge sold 116 Gilead Sciences shares in Q1 2026, an estimated $14.2K.
Legacy Bridge first reported a position in Gilead Sciences in Q4 2018 and held it in 16 quarters.
Legacy Bridge's Gilead Sciences position peaked at $200K in Q2 2019.
2,327 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.